Company: CMND
Filing Date: 2025-11-17
Form Type: 424B5
Source: 0001213900-25-111233
Chunk: 3

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-17
Form: 424B5
Chunk 3
---
 or varies from the information contained in
the accompanying prospectus or any document filed prior to the date of this prospectus supplement and incorporated herein or therein by
reference, the information in this prospectus supplement will control; provided, that if any statement in one of these documents is inconsistent
with a statement in another document having a later date, the statement in the document having the later date modifies or supersedes the
earlier statement. In addition, this prospectus supplement and the accompanying prospectus do not contain all of the information provided
in the registration statement that we filed with the SEC that contains the accompanying prospectus (including the exhibits to the registration
statement). For further information about us, you should refer to that registration statement, which you can obtain from the SEC as described
elsewhere in this prospectus supplement under “Where You Can Find Additional Information.” You may obtain a copy of this prospectus
supplement, the accompanying prospectus and any of the documents incorporated by reference without charge by requesting it from us in
writing or by telephone at the following address or telephone number: Clearmind Medicine Inc., 101 – 1220 W. 6th Ave, Vancouver,
BC V6H1A, Attention: Alan Rootenberg, Chief Financial Officer, telephone number: +1 973.536.1016.

You should rely only on the
information contained in or incorporated by reference into this prospectus supplement and the accompanying prospectus. We have not authorized
anyone to provide you with information that is different. No dealer, salesperson or other person is authorized to give any information
or to represent anything not contained in or incorporated by reference into this prospectus supplement and the accompanying prospectus,
and you must not rely upon any information or representation not contained in or incorporated by reference into this prospectus supplement
or the accompanying prospectus. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or solicitation
of an offer to buy these securities in any circumstances under which the offer or solicitation is unlawful. We are offering to sell, and
seeking offers to buy, our securities offered hereby only in jurisdictions where offers and sales are permitted. You should not assume
that the information we have included in this prospectus supplement or the accompanying prospectus is accurate as of any date other than
the date of this prospectus supplement or the accompanying prospectus, respectively, or that any information we have incorporated by reference
is accurate as of any date other than the date